Buyer: NHS EnglandSupplier: AGB Pharma; AMAROX LIMITED; Abbvie Ltd; Aguettant Ltd; Alissa Healthcare Research Limited; Aspire Pharma Ltd; Aventis Pharma ltd t/a Sanofi; B. Braun Medical Limited; Bowmed Ibisqus Ltd; CST PHARMA LIMITED; Colonis Pharma Ltd; Consilient Health Ltd; DR REDDY'S LABORATORIES (UK) LIMITED; Day Lewis Medical Ltd; Desitin Pharma Ltd; Ennogen Healthcare Ltd; Esteve Pharmaceuticals Limited; Flexipharm Austrading Ltd; Flynn Pharma Ltd; Fresenius Kabi Limited; GH Pharma Ltd; GLENMARK PHARMACEUTICALS EUROPE LIMITED; Gennisium Pharma; Gerot Lannach UK Ltd; GlaxoSmithKline UK Limited; Healthcare Pharma Ltd; Ipca Laboratories UK Ltd; Janssen-Cilag Ltd; Kent Pharma Ltd; Lucane Pharma; MERCURY PHARMACEUTICALS LIMITED; Macleods Pharma UK Limited; Martindale Pharma; Medreich PLC; Milpharm Ltd/aurobinbdo Primary; Morningside Pharmaeuticals; Mylan; NOVUMGEN LIMITED; Neuraxpharm UK Ltd; Organon Pharmaceuticals UK Ltd; Otsuka Pharmaceuticals UK Limited; PARI; Panpharma UK Limited; Perennial Pharma Ltd; Pfizer Ltd; Piramal Critical care Limited; ROSEMONT PHARMACEUTICALS LTD; ROVI Biotech Limited; Roma Pharmaceuticals Limited; Sandoz Ltd; Seacross Pharmaceuticals Ltd; Selective Supplies Limited; Sobi (Swedish Orphan Biovitrum Ltd); Sun Pharma UK Ltd; Teva UK Limited; Thornton and Ross Ltd; Tillotts Pharma UK Ltd; Torbay Pharmaceuticals; Venture Healthcare Ltd; Wockhardt UK Limited; ZENTIVA PHARMA UK LIMITED; hameln pharma ltd; medac Pharma LLP